We propose the formation of a CCOP consortium of three Pediatric Oncology Groups. This funding will allow these previously independent, but co-operating groups, to register and enter patients onto the open protocols of the Children's Cancer Study Group (CCSG ). The overall aims of the CCOP proposal are to test the concept that Community based Oncology care will be improved as more eligible patients using the guidelines of the CCOP proposal. We will specifically test this thesis in a population of pediatric Oncology patients using the guidelines of the CCOP proposal. The CCOP Consortium members represent a unique combination of units. As a group, we cover a wide geographic area in Inland Northern Califormia with an overlapping population base of greater than 2.5 million. Our consortium member groups are presently the only medical subspecialists trained and organized specifically to deliver care to the pediatric oncology populations in that area.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Cooperative Clinical Research--Cooperative Agreements (U10)
Project #
5U10CA035138-03
Application #
3557550
Study Section
(SRC)
Project Start
1983-09-15
Project End
1987-08-31
Budget Start
1985-09-01
Budget End
1987-08-31
Support Year
3
Fiscal Year
1985
Total Cost
Indirect Cost
Name
Kaiser Foundation Research Institute
Department
Type
DUNS #
City
Oakland
State
CA
Country
United States
Zip Code
94612
Chowdhury, Marzana; Euhus, David; Onega, Tracy et al. (2017) A model for individualized risk prediction of contralateral breast cancer. Breast Cancer Res Treat 161:153-160
Parsons, Helen M; Harlan, Linda C; Stevens, Jennifer L et al. (2014) Treatment of small cell lung cancer in academic and community settings: factors associated with receiving standard therapy and survival. Cancer J 20:97-104
Parsons, Helen M; Harlan, Linda C; Seibel, Nita L et al. (2011) Clinical trial participation and time to treatment among adolescents and young adults with cancer: does age at diagnosis or insurance make a difference? J Clin Oncol 29:4045-53
Harlan, Linda C; Lynch, Charles F; Ballard-Barbash, Rachel et al. (2011) Trends in the treatment and survival for local and regional cutaneous melanoma in a US population-based study. Melanoma Res 21:547-54
Belle, Fabiƫn N; Kampman, Ellen; McTiernan, Anne et al. (2011) Dietary fiber, carbohydrates, glycemic index, and glycemic load in relation to breast cancer prognosis in the HEAL cohort. Cancer Epidemiol Biomarkers Prev 20:890-9
Wiggins, Charles L; Harlan, Linda C; Nelson, Harold E et al. (2010) Age disparity in the dissemination of imatinib for treating chronic myeloid leukemia. Am J Med 123:764.e1-9
Neuhouser, Marian L; Nojomi, Marzieh; Baumgartner, Richard N et al. (2010) Dietary fat, tamoxifen use and circulating sex hormones in postmenopausal breast cancer survivors. Nutr Cancer 62:164-74
Hill, Deirdre A; Nibbe, Andrea; Royce, Melanie E et al. (2010) Method of detection and breast cancer survival disparities in Hispanic women. Cancer Epidemiol Biomarkers Prev 19:2453-60
Neuhouser, Marian L; Bernstein, Leslie; Hollis, Bruce W et al. (2010) Serum vitamin D and breast density in breast cancer survivors. Cancer Epidemiol Biomarkers Prev 19:412-7
Harlan, Linda C; Zujewski, Jo Anne; Goodman, Marc T et al. (2010) Breast cancer in men in the United States: a population-based study of diagnosis, treatment, and survival. Cancer 116:3558-68

Showing the most recent 10 out of 15 publications